Global Vitreous Tamponades Market Growth Accelerated by Rising Ophthalmic Disease Prevalence
Vitreous tamponades are a class of drugs used for the treatment of various ophthalmic diseases and disorders. They act as intraocular tamponading agents to help repair retinal detachments or breaks during retina surgery. Vitreous tamponades offer benefits like good safety profile, compatibility with the eye, and ease of use during surgery. The increasing prevalence of retinal detachment and other eye disorders worldwide has boosted the demand for vitreous tamponades. The global Vitreous Tamponades Market is estimated to be valued at US$ 76.00 Mn in 2023 and is expected to exhibit a CAGR of 2.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the major trends fueling the growth of the vitreous tamponades market is the rising geriatric population globally. Age-related ophthalmic conditions like retinal detachment and macular degeneration are more common among the elderly. As per WHO, the number of people aged 65 years and above is projected to grow from an estimated 524 million in 2010 to nearly 1.5 billion in 2050. This demographic shift will drive the demand for vitreous tamponades over the next few years. Another key trend is the growing popularity of silicone-based vitreous tamponades owing to their longer retention time compared to traditional gases. New formulations and delivery forms being introduced by market players are also expanding the applications of vitreous tamponades.
Segment Analysis
The global vitreous tamponades market can be segmented based on product type, end-user, and region. Based on product type, the silicone oil segment held the largest market share in 2023 and is expected to remain the dominating sub-segment over the forecast period. Silicone oil is the most commonly used tamponade agent in vitreoretinal surgeries due to its properties like decreased surface tension, safe formulation, the ease of removal, and availability in different viscosities.
Key Takeaways
The global vitreous tamponades market is expected to witness high growth over the forecast period.
Regional analysis: North America accounted for the largest share of the global market in 2023 due to rapid uptake of technological advancements in ophthalmology, high healthcare expenditure, and presence of key players. However, Asia Pacific is expected to grow at the highest CAGR during the forecast period owing to large population base, increasing cases of retinal detachment, and growing medical tourism.
Key players: Key players operating in the vitreous tamponades market are Alchimia srl, Alcon, Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, Croma-Pharma GmbH, Dutch Ophthalmic Research Center (International) B.V., and Fluoron GmbH.

Comments
Post a Comment